creased and directly correlated with the extent of interstitial fibrosis. Immunohistochemical staining demonstrated that PAR-2 protein expression in IgAN biopsies was mainly localized in the proximal tubuli and within the interstitial infiltrate. Proximal tubular cells in culture expressed PAR-2. Activation of this receptor by FXa in tubular cells induced a striking increase in intracellular calcium concentration. In addition, incubation of both cell lines with trypsin, FXa, or PAR-2 activating peptide caused a marked upregulation of PAI-1 gene expression that was not counterbalanced by an increased expression of plasminogen activators. Finally, PAR-2 activation induced a significant upregulation of TGF-␤ gene and protein expression in both mesangial and tubular cells. On the basis of our data, we can suggest that PAR-2 expressed by renal resident cells and activated by either mast cell tryptase or FXa may induce extracellular matrix deposition modifying the PAI-1/PA balance and inducing TGF-␤ expression. These molecular mechanisms may underlie interstitial fibrosis in IgAN.
An increasing body of evidence suggests that proteases may play a key role in the pathogenesis of tissue fibrosis (1) (2) (3) (4) (5) (6) . Several of these enzymes, including metalloproteases, collagenases, gelatinases, plasmin, and plasminogen activators (PA), can directly catalyze the degradation of extracellular matrix (ECM) components (1, 2, 5) . Thus, an unbalance between these proteases and their specific inhibitors may promote ECM deposition. In the large family of protease inhibitors, plasminogen activator inhibitor-1 (PAI-1) is the most heavily involved in tissue fibrosis (7) . PAI-1 gene expression is strikingly induced by TGF-␤ and may play a key role in the powerful profibrotic action of this growth factor (7) . Interestingly, an increased expression of this inhibitor of plasminogen activation has been demonstrated in several progressive renal diseases, including IgA nephropathy (IgAN) (8 -10) .
On the other hand, different serine proteases, directly interacting with specific proteolytically activated cell-surface receptors, can modulate several cell functions including the expression and production of ECM components and/or profibrotic mediators (11) (12) .
Since the cloning of thrombin receptor, the first of these peculiar proteolytically activated receptors, a growing interest has been focused on the cell-activating properties of proteases, and in the last few years, three more protease-activated receptors (PAR) have been cloned and characterized (13) (14) (15) (16) . In this small family of G protein-coupled receptors, PAR-2 is the only one that does not interact with thrombin, but can be activated by trypsin-like proteolytic enzymes, including mast cell tryptase (14, (17) (18) (19) (20) .
Tryptase is one of the main components of mast cell secretory granules that can be released on cell activation. Mast cell infiltration has often been observed in chronic inflammation leading to tissue fibrosis in different organs, including lung, skin, and kidney (21) (22) (23) (24) . In particular, the presence of these immune cells has been described within the interstitial space in IgAN (22) . Interestingly, the extent of the infiltration was directly and significantly correlated with the degree of interstitial fibrosis (22) . Although mast cells have been suggested to play a pivotal role in the pathogenesis of fibrotic processes, the mechanisms underlying their potential fibrogenic action is still largely unclear.
Recently, different investigators reported that PAR-2 may also represent the cell-surface receptor for activated coagulation factor X (FXa) (25, 26) . Coagulation cascade activation is a prominent feature of both acute and chronic inflammatory processes. Several reports support the hypothesis of a key role for coagulation factors in the pathogenesis of tissue fibrosis, particularly within the kidney (8, (27) (28) (29) (30) . Interestingly, earlier works suggested that FXa, the enzymatically active constituent of the prothrombinase complex, triggers complex pathways involved in the regulation of cellular growth (31, 32) . Binding of FXa to vascular endothelial cells induces the release of PDGF-like molecules, thus providing a paracrine mechanism for cell proliferation (33) . Moreover, we have recently demonstrated that FXa directly stimulates proliferation of human mesangial cells, an event that has been shown to precede the development of glomerulosclerosis (34) .
Thus, in this study, we investigated PAR-2 gene expression in a primary glomerulonephritis often characterized by tubulointerstitial involvement, namely IgAN, and evaluated the effect of its activation on the potential mechanisms involved in renal interstitial fibrosis.
Materials and Methods

Patients
Seventeen patients with biopsy-proven IgAN, having given their informed consent, were enrolled into the study. Mean age was 36 yr (range, 21 to 45), mean serum creatinine, 1.2 mg/dl (range, 0.8 to 1.8), mean daily proteinuria, 1.2 g/24 h (range, 0.5 to 3.0). Ten apparently normal portions of human kidneys removed for renal carcinoma were used as control.
The histologic diagnosis of IgAN was supplemented by grading the disease severity according to Lee et al. (35) . The patients were divided into three groups: mild (G1 to G2, eight patients), moderate (G3, five patients), and severe histologic lesions (G4 to G5, four patients).
Microscopy Study
The histologic elementary lesions were quantified by a computerbased morphometric analysis system. The video image was generated by a video camera (Hamamatsu, Milan, Italy) connected, through a frame grabber (Hamamatsu, Milan, Italy), to a Power PC computer (Macintosh, Cupertino, CA). Single images were digitized for image analysis at 256 gray levels. Imported data were analyzed quantitatively by Optilab Pro 2.6.1 software (Graftek, Villanterio, Italy). An optical threshold and filter combination was set to select only the interstitial extracellular matrix (evaluated by Masson's trichromic staining). Six to ten randomly selected interstitial areas from each biopsy were analyzed. The structures of interest were interactively discriminated by the operators using the cursor and then automatically measured. Areas of interstitial fibrosis (identified by Masson's trichromic staining) were extracted by "hue saturation method" and expressed as percentage of discriminated regions. Using Stat-View II (BrainPower, Calabasas, CA), the single datum for each variable was tabulated and Pearson's correlation coefficients were calculated.
RNA Extraction and Reverse-Transcription PCR (RT-PCR)
Total RNA was isolated from biopsy cores, normal kidney fragments, and cultured cells by the single-step method, using phenol and chloroform/isoamylalcohol (36) . One microgram of total RNA was used in an RT reaction. Twenty l of the reaction mixture containing 1 g of total RNA, PCR buffer (10 mM Tris-HCl, pH 8.3, 50 mM KCl), 5 mM MgCl 2 , 1 mM dNTP s , 20 U of RNase inhibitor, 2.5 mM of oligo (dT), and 100 U of Moloney murine leukemia virus reverse transcriptase were incubated at 42°C for 30 min, and then heated to 95°C for 5 min to inactivate the enzyme activity and to denature RNA-cDNA hybrids (37) . PCR was performed with two separate sets of oligonucleotide primers specific for human PAR-2 and glyceraldehyde phosphate dehydrogenase (GAPDH), respectively.
For PAR-2, upstream: 5'-TGGGTTTGCCAAGTAACGGC-3', and downstream: 5'-GGGAGATGCCAATGGCAATG-3'. For GAPDH, upstream: 5'-TGG TAT CGT GGA AGG ACT CAT GAC-3', and downstream: 5'-ATG CCA GTG AGC TTC CCG TTC AGC-3'.
PAR-2 and GAPDH cDNA amplification was performed in two separate sets of reactions at a final concentration of 1x PCR buffer, 1.5 mM MgCl 2, 200 M dNTP s , 0.15 M of PAR-2 primers or 0.15 M GAPDH primers, and 1.25 U of AmpliTaq DNA polymerase (Perkin Elmer Cetus, Boston, MA), in a total volume of 50 l. The amplification profile involved denaturation at 95°C for 1 min, primer annealing at 61°C for PAR-2 or at 55°C for GAPDH for 1 min, and extension at 72°C for 1 min. PCR products were electrophoresed in 1.6% agarose gel in Tris borate/EDTA buffer, loading 10 l of either PAR-2 or GAPDH PCR products for each sample. The expected size of the amplified fragments was 320 bp and 450 bp for PAR-2 and GAPDH, respectively. Intensity of the PAR-2 and GAPDH bands was quantified by computer-assisted densitometry (Optilab 2.6.1). Results were expressed as PAR-2 to GAPDH ratios.
Immunohistochemistry
PAR-2 protein expression was evaluated on frozen 4-m-thick kidney sections fixed in 4% paraformaldehyde, using a specific mouse monoclonal anti-human PAR-2 antibody directed against an epitope that is retained after PAR-2 cleavage at 1:20 dilution. Immobilized mouse antibodies were detected by the immunoalkaline phosphatase (APAAP) method with affinity-purified rabbit anti-mouse IgG (Dako, Milan, Italy) and APAAP complex (1:50 dilution; Dako), after a two steps technique as described previously (19) . Alkaline phosphatase was developed with New Fuchsin (Sigma, Milan, Italy). Negative controls were performed by omitting the primary or secondary antibodies, and employing nonimmune mouse or rabbit antiserum as first layer. The protein expression levels were assessed semiquantitatively by two independent pathologist (GG and LG) in blind.
Cell Culture
HK2, an immortalized proximal tubular cell line from normal, adult human kidney (38) , was obtained from ATCC (Rockville, MD). Cells were grown to confluence in DMEM/F12 medium supplemented with 5% FBS, 100 U/ml penicillin, 100 g/ml streptomycin, 2 mM Lglutamine, 5 g/ml insulin, 5 mg/ml transferrin, 5 ng/ml sodium selenite, 5 pg/ml T3, 5 ng/ml hydrocortisone, 5 pg/ml PGE1, and 10 ng/ml EGF. For passage, confluent cells were washed with PBS, removed with 0.05% trypsin/0.5 mM EDTA in PBS, and plated in DMEM/F12. In a separate set of experiments, for passage, cells were washed twice with Hanks' balanced salt solution without calcium, incubated with 1 mM EDTA in PBS, and removed by gentle scraping using a rubber policeman.
Western Blotting
HK2 cells were grown in 60-mm Petri dishes to confluence in RPMI (Gibco, Grand Island, NY) containing 17% FBS and lysed in 100 l of RIPA buffer (1 mM phenylmethylsulphonylfluoride, 5 mM EDTA, 1 mM sodium orthovanadate, 150 mM sodium chloride, 8 g/ml leupeptin, 1.5% nonidet P-40, 20 mM Tris-HCl; pH 7.4). The lysates were set on ice for 30 min, centrifuged at 12,000 ϫ g at 4°C for 5 min, and the supernatants were collected and stored at Ϫ80°C until used. Aliquots containing 20 g of proteins from each lysate were subjected to SDS/PAGE on 7.5% gels under reducing conditions and then electrotransferred onto nitrocellulose membranes (Hybond C; Amersham, United Kingdom). After blocking nonspecific binding through incubation with 2% BSA and 0.1% Tween-20 in PBS (TBS) overnight at room temperature, the membranes were incubated with monoclonal anti-human PAR-2 antibody (Research Diagnostics, NJ) at room temperature for 3 h. The membranes were washed twice in TBS and then incubated with horseradish-peroxidase-conjugated sheep anti-mouse antibody at 1:1,500 dilution in 0.1% Tween-20 in PBS for 2 h at room temperature. The membranes were washed three times at room temperature in TBS and then once with 0.1% SDS in PBS. The ECL enhanced chemiluminescence system (Amersham) was used for detection.
Measurements of [Ca 2ϩ
]i [Ca 2ϩ ]i was measured at 37°C by dual-wavelength fluorescence microscopy in groups of seven to ten HK2 cells loaded with the Ca 2ϩ sensitive indicator fura 2, as described previously (34) . Briefly, cells seeded at a density of 2 ϫ 10 4 per 24-mm diameter round glass coverslips were loaded with 3 to 10 m fura 2 acetoxymethylesther in serum-free medium at 37°C and 5% CO 2 for 60 min. Coverslips were rinsed twice and then incubated with FXa at 37°C in Krebs-Ringer-HEPES (KRH) buffer (125 mm NaCl, 5 mm KCl, 1.2 mm KH 2 PO 4 , 1.2 mm MgSO 4 , 2 mm CaCl 2 , 265 mm HEPES, 6 mm glucose).
[Ca 2ϩ ]i-dependent fluorescence was measured with a microfluorometer (Cleveland Bioinstrumentation, Cleveland, OH) connected to a Zeiss IM35 inverted microscope equipped with a Nikon CF X40 fluor objective. Recordings were performed at 340-and 380-nm excitation wavelengths (bandwidth, 0.5 nm). Emission was collected by a photomultiplier carrying a 505-nm cutoff filter. Emission from 340 and 380 nm and real-time 340-to-380 nm ratios were recorded by a specific software (Labview; National Instruments Corporation, Austin, TX). In each experiment, maximal fluorescence ratio was determined by addition of Ca 2ϩ ionophore ionomycin, and minimal fluorescence ratio by addition of 7.5 mM EGTA and 60 mM Tris (hydroxymethyl) aminomethane HCl (pH 10.5). Fura 2 dissociation constant was assumed to be 224 nM. [Ca 2ϩ ]i was calculated using a previously described formula (39) .
Northern Blotting
HK2 cells, grown to confluence, were serum-starved for 48 h and then treated for 3, 6, and 24 h with either trypsin (200 nM; Sigma), FXa (20 nM; Calbiochem), or PAR-2 activating peptide (PAP; SLI-GRL; Sigma Genosys, Milan, Italy). In a separate set of experiments, proximal tubular cells stimulated with trypsin were coincubated with a neutralizing anti-TGF-␤ antibody (50 g/ml; Genzyme, Cambridge, MA).
At the end of incubation, cells were lysed with 4 M guanidium isothiocyanate containing 25 mM sodium citrate, pH 7.0, 0.5% sarcosyl, and 0.1 mM 2-␤-mercaptoethanol. Total RNA was isolated by the single-step method, with phenol and chloroform/isoamylalcohol extractions (36) .
PAI-1, u-PA, and TGF-␤ mRNA levels were studied by Northern blotting as described previously (40) . Briefly, electrophoresis of 20 g of total RNA from each experimental condition was carried out in 1% agarose gel with 2.2 M formaldehyde. The RNA was then transferred overnight onto a nylon membrane (Schleicher and Schuell, Dassel, Germany). The membrane was stained with ethidium bromide to evaluate the 28S and 18S ribosomal bands and prehybridized at 42°C for 2 h in 50% Formamide, 0.5% SDS, 5x SSC, and 0.1 mg/ml salmon sperm DNA. Fragments of the human PAI-1, u-PA, t-PA, and TGF-␤ cDNA were used as probes (40) . The DNA fragments were labeled by random priming using a commercially available kit (Amersham) and [ 32 P]dCTP (specific activity: 3,000 Ci/mmol). The probes (10 6 cpm/ml) were added to 10 ml of prehybridization solution and the blots were hybridized for 16 h at 42°C. The membranes were then washed once in 2x SSC, 0.1% SDS at room temperature for 5 min, once in the same buffer at 55°C for 30 min, and in 1x SSC, 0.1% SDS at 55°C for a further 30 min. After drying, membranes were exposed to a Kodak X-OMAT film with intensifying screens at Ϫ70°C.
The intensity of specific mRNA bands was quantified by computerassisted densitometry (Optilab 2.6.1) and normalized to the intensity of the 28S bands on the ethidium bromide-stained blots.
ELISA
HK2 cells plated in 6-well dishes and grown to 70% of confluence were serum-starved for 24 h and then incubated 24 h in serum-free medium with or without FXa (20 nM) or trypsin (50 nM), respectively. At the end of incubation, the supernatant was harvested, centrifuged for 10 min at 1,000 ϫ g to remove the cell debris, and stored at Ϫ80°C until used. TGF-␤ measurement in the supernatant was performed using a commercial human TGF-␤ ELISA kit (Quantikine R&D, Abingdon, UK). This is a multiple sandwich solid-phase enzyme immunoassay, which uses a specific monoclonal antibody raised against human TGF-␤. The sensitivity of the ELISA is 31 pg/ml. The TGF-␤ concentration of the unknown samples was determined by interpolation into a standard curve developed with known amounts of recombinant human TGF-␤ protein. TGF-␤ protein concentration was normalized to cell counts.
Statistical Analysis
Data are expressed as mean Ϯ SD. Quantitative data were compared among the groups by ANOVA. The correlation coefficients are Pearson's r values. Differences were considered to be significant when P Ͻ 0.05.
Results
PAR-2 Expression in IgAN
PAR-2 gene expression was evaluated in renal biopsies from seventeen IgAN patients with mild (n ϭ 8), moderate (n ϭ 5), and severe (n ϭ 4) renal lesions. The mRNA levels for this protease receptor, barely detectable in control kidneys, were upregulated in the biopsy samples collected from IgAN patients ( Figure 1A) . The quantitation of the signal, shown in Figure 1B , demonstrated a statistically significant difference between the normal kidneys and IgAN renal biopsies, particularly in patients with moderate and severe lesions. Interestingly, PAR-2 gene expression was directly and significantly correlated with the extent of tubulointerstitial fibrosis ( Figure  1C ), whereas no correlation was observed either with the degree of glomerular sclerosis (r ϭ 0.1, P ϭ 0.08) or the extent of the mononuclear cell infiltrate (r ϭ 0.1, P ϭ 0.09). PAR-2 gene expression was also directly and significantly correlated with serum creatinine (r ϭ 0.39, P ϭ 0.04), but not with the daily proteinuria (r ϭ 0.2, P ϭ 0.07) at the time of biopsy.
PAR-2 protein expression was then evaluated by immunohistochemistry using a specific monoclonal antibody. In normal kidney, PAR-2 was barely detectable, mainly within the vessel wall (Figure 2A) . In IgAN biopsies, there was a striking increase in PAR-2 protein expression particularly at the proximal tubular level (Figure 2 , B and C) and within the mononuclear interstitial infiltrate ( Figure 2D ). Finally, there was an increased PAR-2 protein expression also at the glomerular level, particularly within parietal epithelial cells ( Figure 2C ).
PAR-2 Expression and Activation in Proximal Tubular Cells
Limited information is available on PAR-2 expression in cultured tubular cells. We therefore investigated PAR-2 gene expression by RT-PCR in cultured proximal tubular cells. These cells expressed PAR-2 mRNA under basal condition ( Figure 3A) . The levels of expression were not modulated by the use of trypsin to detach the cells (data not shown). To confirm the PCR data, we also evaluated PAR-2 protein expression. A single band of the expected molecular weight was present in the cell lysates from tubular cells ( Figure 3B ), and also in this case cells detached by trypsin or scraping did not present any difference in PAR-2 protein expression (data not shown). Activation of all four known PAR results in the induction of phospholipase C activity with the subsequent increase in intracellular calcium concentration (13) (14) (15) (16) . To confirm a functional relevance of PAR-2 expression, the activation of PLC was studied indirectly by measuring the cytosolic calcium levels in groups of seven to ten human proximal tubular cells stimulated with trypsin. Increases in [Ca 2ϩ ] i rapidly occurred, peaked within a few minutes, and declined slowly to reach a plateau at a slightly elevated steady state level, which was then maintained for several minutes ( Figure  3C ). This pattern resembles the one previously observed in FXa-stimulated mesangial cells (34) .
PAR-2 Activation and PAI-1 Gene Expression
PAI-1 is a powerful anti-fibrinolytic and profibrotic mediator whose expression is significantly increased in several renal diseases characterized by interstitial fibrosis and glomerulosclerosis, including IgAN (7). To evaluate the potential role of PAR-2 overexpression in the pathogenesis of progressive interstitial damage in IgAN, the effect of its activation on PAI-1 mRNA levels was studied in cultured proximal tubular cells.
To this purpose, we tested two well-known agonist of PAR-2, FXa and trypsin. In addition, to confirm the involvement of this protease-activated receptor in the modulation of PAI-1 gene expression, we also used a peptide corresponding to PAR-2 tethered ligand (PAP). FXa, trypsin, and PAP caused an increase of PAI-1 mRNA abundance in tubular epithelial cells (Figure 4, A to F) . PAI-1 gene expression induced by PAR-2 activation was equivalent to thrombin-stimulated PAI-1 mRNA levels in proximal tubular cells (Figure 4, G and H) . PAR-2 to glyceraldehyde phosphate dehydrogenase (GAPDH) ratios in normal kidneys (controls) and IgAN patients. PAR-2 and GAPDH expression were quantified by computer-assisted densitometry as described in Materials and Methods. PAR-2 expression in renal tissue was then normalized to GAPDH mRNA abundance. *P Ͻ 0.01 versus controls. (C) Correlation between PAR-2 expression, quantified by computer-assisted densitometry, and the degree of tubulointerstitial damage as assessed semiquantitatively by two independent observers. r ϭ 0.6, P Ͻ 0.01. To assess the specificity of the staining in some of the sections, we omitted the incubation with the primary antibody (E). Magnification: ϫ200 (A, B, and E), ϫ1,000 (C), and ϫ400 (D).
PAR-2 Activation and u-PA Gene Expression
The strong induction of PAI-1 gene expression by PAR-2 activation was not counterbalanced by an increased expression of u-PA, the only plasminogen activator produced by proximal tubular cells. Indeed, PAR-2 activation by both FXa and PAP did not influence at all u-PA mRNA levels in proximal tubular cells ( Figure 5, A to D) . Thrombin, on the other hand, strikingly upregulated the expression of u-PA in these cells ( Figure  6 , E and F).
PAR-2 Activation and TGF-␤ Expression
Several reports suggested TGF-␤ as the key pathogenic mediator of interstitial fibrosis and glomerulosclerosis (41) . In addition, TGF-␤ stimulates an increased PAI-1 gene expression in several cell lines (7) . Thus, we investigated whether PAR-2 activation could induce TGF-␤ gene expression and protein release. Both trypsin and FXa incubation significantly induced TGF-␤ gene and protein expression in proximal tubular cells ( Figure 6 ). However, trypsin-induced PAI-1 gene expression was not inhibited by preincubation with a specific neutralizing anti-TGF-␤ antibody ( Figure 7 ).
Discussion
In this study, we demonstrated for the first time an increased gene expression of PAR-2 in IgAN renal biopsies. Interestingly, the PAR-2 mRNA levels correlated directly and significantly with the extent of fibrosis, suggesting a potential role for this protease-activated receptor in the deposition of extracellular matrix, in particular at the tubulointerstitial level. Interestingly, the PAR-2 protein expression was mainly localized within proximal tubular cells, although the mononuclear infiltrating cells also expressed this receptor at high levels.
Although discovered in 1994 by reduced stringency cloning from a murine cDNA library (14) , the in vivo pathophysiological role of PAR-2 remains poorly understood. PAR-2 is widely expressed by vascular endothelial (42) (43) (44) and smooth muscle cells (45, 46) , and is thought to play a role in the regulation of BP and vascular tone (47) . It belongs to the family of G protein-coupled receptors activated by limited proteolysis. After the cleavage of its extracellular domain, a new amino terminus peptide is exposed that functions as a tethered ligand, causing the autoactivation of the receptor. Although PAR-2 was originally reported as the trypsin receptor, it is now clear that its activation may be induced also by other serine proteases including mast cell tryptase (17) and FXa (26). Several lines of evidences suggest that both tryptase and FXa may be present in a significant amount at the glomerular and tubulointerstitial level in several chronic nephropathies, including IgAN.
Tryptase is one of the main components of mast cell secretory granules that can be released on cell activation. Mast cell infiltration has often been observed in chronic inflammation leading to tissue fibrosis in different organs, including lung, liver, skin, and kidney (21) (22) (23) (24) . In particular, the presence of these immune cells was recently described within the interstitial space in IgAN by different authors (22) . Interestingly, the E) , and thrombin (G), harvested at the indicated time points and then total RNA was extracted. PAI-1 mRNA expression was studied by Northern blot analysis (upper panel). 28S and 18S ribosomal RNA bands on ethidium bromide-stained gel were used to control the RNA loading (lower panel). Intensity of specific mRNA bands was quantified by computer-assisted densitometry, normalized to the intensity of the 28S bands on the ethidium bromide-stained blots, and expressed as PAI-1/28S ratio (B, D, F, and H, mean Ϯ SD of three separate experiments). *P Ͻ 0.001 versus 0 h. extent of the infiltration was directly and significantly correlated with the degree of interstitial fibrosis (22) .
Coagulation cascade activation is a prominent feature of both acute and chronic inflammatory processes (30) . Indeed, indirect evidence of coagulation cascade activation within the interstitial area has also been reported in several renal diseases (48, 49) .
PAR-2 expression within the normal kidney was originally reported by Nystedt et al. (14) , but these authors did not specify the cellular localization in whole kidney and did not investigate any specific renal cell line. Recently, Bertog et al.
were the first to describe the presence of PAR-2 on the basolateral membrane of collecting ducts (50) . The pathophysiologic role of PAR-2 activation in renal resident cells is poorly defined. Recently, Kondo et al. observed a significant mitogenic and profibrotic effect of mast cell tryptase on interstitial renal fibroblast (51) . We previously reported that FXa can induce DNA synthesis and PDGF gene expression in human cultured mesangial cells (34) . Interestingly, we demonstrated that the cellular effects of this coagulation protease was dependent on its enzymatic activity and did not depend on its previously identified receptor, EPR-1, that is not expressed by An increasing body of evidence suggests that inhibition of plasminogen activator by PAI-1 may play a central role not only in preserving fibrin deposits, but also in the development of interstitial fibrosis and glomerular sclerosis (7) . Indeed, , and 24 h, and then total RNA was extracted. TGF-␤ mRNA expression was studied by Northern blot analysis (upper panel). 28S and 18S ribosomal RNA bands on ethidium bromide-stained gel were used to control the RNA loading (lower panel). Intensity of specific mRNA bands was quantified by computer-assisted densitometry, normalized to the intensity of the 28S bands on the ethidium bromide-stained blots and expressed as TGF-␤/28S ratio (B and D, mean Ϯ SD of three separate experiments). *P Ͻ 0.001 versus 0 h. (E and F) Serum-starved proximal tubular cells were incubated in serum-free medium in the presence and in the absence of FXa (E) or trypsin (F). After 24 h, supernatant was collected and cells were harvested and counted. TGF-␤ concentration in the conditioned medium was evaluated by ELISA and normalized to cell count. *P Ͻ 0.01 versus control. , and harvested after 6 h. Total RNA was extracted and PAI-1 gene expression was studied by Northern blot analysis (A, upper panel) as described in Materials and Methods. 28S and 18S ribosomal RNA bands on ethidium bromidestained gel were used to control the RNA loading (A, lower panel). Intensity of specific mRNA bands was quantified by computer-assisted densitometry, normalized to the intensity of the 28S bands on the ethidium bromide-stained blots, and expressed as PAI-1/28S ratio (B, mean Ϯ SD of three separate experiments). *P Ͻ 0.001 versus basal.
plasmin as well as plasminogen activators can induce ECM degradation directly or through the activation of metalloproteases (7). Thus, an increased PAI-1 expression reducing the turnover of ECM components may cause their abnormal accumulation, leading to tissue fibrosis. In two different studies, it has been shown that PAI-1 is a key player in the induction of postinflammatory pulmonary fibrosis. Fibrinous alveolitis induced in mice either by intratracheal administration of bleomycin or by hyperoxic atmosphere is followed by progressive pulmonary fibrosis (56) . Disruption of the PAI-1 gene was shown to decrease the accumulation of fibrin in the lungs of experimental animals and to prevent most of the pulmonary fibrosis (56) . Conversely, overexpression of PAI-1 in transgenic mice increased both fibrin accumulation and the severity of the subsequent fibrosis (57) . Recently, Hattori et al. demonstrated that PAI-1 effect on lung fibrosis induced by bleomycin is completely independent from fibrin deposition (57) . Indeed, fibrinogen null mice developed fibrosis to a degree similar to heterozygous mice, which present an almost normal plasma fibrinogen level (57) . These data strongly support the pathogenic involvement of PAI-1 in organ fibrosis.
PAI-1 expression is almost undetectable in normal mouse, rat, and human kidney by immunohistochemistry and in situ hybridization (7) . Several studies have shown that PAI-1 synthesis and deposition are promoted in the kidney during experimental and human nephropathies, including IgAN (7). PAI-1 expression by endothelial, mesangial, and even tubular epithelial cells may occur along with an inflammatory reaction associated with an activation of coagulation and fibrin deposition or even in fibrin-independent kidney injuries such as diabetes, focal segmental sclerosis, and cyclosporine A nephropathy (7). PAI-1 deposition is associated with ECM expansion and fibrosis, showing that PAI-1 may be a component of the ECM and suggesting that it could play a role in the turnover of the ECM.
Whether the activation of the coagulation cascade might modulate the fibrinolytic system has been largely discussed. Several groups of investigators reported the ability of thrombin to cause an increased PAI-1 gene expression in a variety of cell lines, potentially reducing the activity of the fibrinolytic system (58, 59 ). However, thrombin was reported to increase also the expression of plasminogen activators (60, 61) . Indeed, in this study we observed that thrombin induced u-PA gene expression in proximal tubular cells, respectively, confirming previous observations. On the other hand, we demonstrated for the first time that PAR-2 activation caused a marked increase in PAI-1 mRNA levels without modifying the expression level of u-PA. Thus, it is conceivable that the overall effect might be an inhibition of fibrinolysis as well as of the physiologic ECM turnover significantly stronger than the one induced by thrombin. In addition, the different expression profile induced by thrombin and FXa rules out the possibility, recently suggested, that FXa may interact and cause the activation of PAR-1, the main known thrombin receptor. Indeed, FXa effects were reproduced by direct PAR-2 activation by its specific agonist peptide.
Finally, we observed a significant increase in TGF-␤ gene and protein expression in proximal tubular cells exposed to PAR-2 agonists. Because TGF-␤ is the well-established mediator of interstitial fibrosis, our observation would strongly support the hypothesis that activation of PAR-2 may play a pathogenic role in the progression of renal damage in IgAN. Interestingly, this powerful profibrotic factor can induce PAI-1 gene expression in several cell lines (7) . However, PAI-1 gene expression induced by PAR-2 activation in tubular cells does not depend on the autocrine effect of TGF-␤. Indeed, the time courses for PAI-1 and TGF-␤ gene expression do not differ significantly, suggesting that newly synthesized TGF-␤ cannot play a significant role in the PAI-1 gene expression induced by PAR-2 activation. In addition, trypsin-induced PAI-1 gene expression was not inhibited by preincubation with a specific neutralizing anti-TGF-␤ antibody.
In conclusion, we can suggest that PAR-2 expressed by renal resident cells and activated either by mast cell tryptase or by FXa may induce an increased ECM deposition modifying the PAI-1/PA balance and inducing TGF-␤ expression. These molecular mechanisms may underlie interstitial fibrosis and renal damage progression in IgAN.
